Anbio Biotechnology

Anbio Biotechnology (Anbio) is a leading global medical device company specializing in in vitro diagnostics (IVD) for both human and veterinary applications. Our mission is to revolutionize diagnostics by personalizing and decentralizing testing, enabling rapid results and improving patient outcomes worldwide. We deliver cutting-edge laboratory, wellness, at-home, and point-of-care (POCT) solutions that are rapid, accessible, and affordable on a global scale. Since our inception, Anbio has been dedicated to providing state-of-the-art diagnostic technologies while ensuring cost-effectiveness for our customers. With strong capabilities in research and development, manufacturing, and global distribution, we continuously focus on cost optimization while offering a comprehensive portfolio of proven laboratory and POCT products. Our human diagnostics portfolio covers cancer, cardiovascular diseases, pharmacogenomics, hormones, infectious diseases, inflammation, and drugs of abuse testing. Our veterinary diagnostics range includes fertility, inflammation, cardiac markers, thyroid hormones, immunological functions, and infectious diseases. Driven by innovation and guided by our commitment to quality, Anbio is shaping the future of diagnostics—making accurate testing faster, more accessible, and more affordable for everyone.